Nuclear translocation of SREBP2 is promoted by inhibition of LATS, significantly reducing E-cadherin expression while upregulating N-cadherin, Snail, and Vimentin, thereby facilitating HCC cell migration and invasion (Zhang et al., 2023). This evidence concerns the gene VIM and hepatocellular carcinoma.